Today: 29 April 2026
Browse Category

NYSE:TMO 23 January 2026 - 15 February 2026

Thermo Fisher (TMO) stock nudges higher after filing for new bond sale tied to Clario deal

Thermo Fisher (TMO) stock nudges higher after filing for new bond sale tied to Clario deal

Thermo Fisher shares rose 0.1% to $543.48 Monday after the company filed for a four-part senior notes offering to help fund its planned Clario acquisition. The preliminary prospectus left key terms blank and showed $39.38 billion in consolidated debt as of Dec. 31, 2025. S&P rated the proposed debt ‘A-’. Executive Gianluca Pettiti filed to sell 400 shares valued at $216,480.
9 February 2026
·
Thermo Fisher stock price: TMO ends week near $543 — what matters before Monday’s open

Thermo Fisher stock price: TMO ends week near $543 — what matters before Monday’s open

Thermo Fisher shares closed Friday at $542.83, up 0.09% for the day but down 6.7% since Feb. 2 after a steep midweek drop. The company’s 2026 forecast cited pressure from U.S. academic research funding cuts and projected adjusted profit of $24.22 to $24.80 a share. The planned $8.9 billion Clario acquisition is expected to close by mid-2026. Broader sector peers outperformed Thermo Fisher into the weekend.
8 February 2026
·
Thermo Fisher stock price today: TMO nudges higher after Thursday drop as investors eye next week’s data

Thermo Fisher stock price today: TMO nudges higher after Thursday drop as investors eye next week’s data

Thermo Fisher shares rose 0.6% to $545.58 Friday afternoon, recovering some ground after a 4% drop Thursday. The move lagged the broader market, with the S&P 500 up 1.73%. Investors remain cautious amid weak academic research funding and uncertain lab order trends. Upcoming U.S. jobs and inflation data could affect rate expectations and valuations.
6 February 2026
··
Thermo Fisher Scientific stock price slides to $578.61 after 2026 outlook; what to watch Monday

Thermo Fisher Scientific stock price slides to $578.61 after 2026 outlook; what to watch Monday

Thermo Fisher Scientific shares fell 2.29% to $578.61 Friday, extending a four-day slide after issuing a cautious 2026 outlook and forecasting earnings below Wall Street’s average estimate. Volume reached 3.7 million shares, nearly double the daily average. The company cited continued pressure from frozen academic research grants. Fourth-quarter revenue rose 7% to $12.21 billion, with adjusted EPS at $6.57.
31 January 2026
·
Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher stock steadies near $220 after earnings slide as 2026 outlook comes into focus

Danaher shares edged up 0.1% to $219.83 Friday after steep losses earlier in the week. The company reported Q4 revenue of $6.84 billion and adjusted EPS of $2.23, with 2026 earnings guidance in line with analyst forecasts. Investors remain cautious amid weak academic research funding and recent stock swings. Vanguard disclosed an 8.63% stake in Danaher as of Dec. 31.
30 January 2026
·····
Thermo Fisher stock slides on 2026 profit outlook as research funding cuts bite — what’s next for TMO

Thermo Fisher stock slides on 2026 profit outlook as research funding cuts bite — what’s next for TMO

Thermo Fisher shares fell 2.6% to $592.16 after the company forecast 2026 profits below Wall Street estimates, citing weaker U.S. academic research funding. The company projected adjusted earnings of $24.22 to $24.80 per share, missing consensus. Fourth-quarter revenue rose 7% to $12.21 billion, beating expectations. CFO Stephen Williamson will retire in March, with Jim Meyer named as successor.
30 January 2026
··
Thermo Fisher (TMO) stock drops after 2026 profit outlook misses on research funding cuts

Thermo Fisher (TMO) stock drops after 2026 profit outlook misses on research funding cuts

Thermo Fisher shares fell 2.6% to $592.08 after the company forecast 2026 adjusted profit below Wall Street estimates, citing continued weakness in U.S. academic and government funding. The firm projected 2026 adjusted EPS of $24.22–$24.80 and revenue of $46.3–$47.2 billion. Fourth-quarter revenue rose 7% to $12.21 billion. Investors are watching the timing of the Clario acquisition, expected to close by mid-2026.
29 January 2026
··
Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher (TMO) stock slides into earnings — here’s what Wall Street is watching

Thermo Fisher shares fell 2.55% to $608.02 Wednesday, their second straight decline ahead of Thursday’s Q4 earnings call. Trading volume topped 2.3 million, above average, as investors weighed Danaher’s warning on weak academic research funding. The stock now sits 5.6% below its Jan. 22 high. Life-science tools stocks broadly declined during the session.
29 January 2026
···
Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

Thermo Fisher Scientific stock rises toward $631 as TMO heads into Jan. 29 earnings

Thermo Fisher shares rose 0.8% to $631.24 by midday Monday in New York, rebounding from an early dip ahead of Thursday’s earnings report and 2026 outlook. Options markets point to an expected 4% swing after results. Analysts forecast Q4 earnings of $6.43 per share, up from $6.10 a year ago. The company will hold its earnings call at 8:30 a.m. ET on Jan. 29.
26 January 2026
··
Thermo Fisher (TMO) stock slips from fresh high as earnings week and Fed decision loom

Thermo Fisher (TMO) stock slips from fresh high as earnings week and Fed decision loom

Thermo Fisher shares fell 2.11% to $625.98 Friday, ending a three-day rally and closing 2.8% below Thursday’s 52-week high. The company reports earnings before the market opens Jan. 29, following Danaher’s results and the Fed’s Jan. 27-28 meeting. The S&P 500 health care index slipped 0.56% Friday. Analyst consensus expects Thermo Fisher to post $6.44 EPS on $11.95 billion revenue for the quarter.
25 January 2026
···
Thermo Fisher (TMO) stock pulls back from a fresh high as Jan. 29 earnings loom

Thermo Fisher (TMO) stock pulls back from a fresh high as Jan. 29 earnings loom

Thermo Fisher Scientific shares fell 2.1% to $625.98 on Friday, reversing after a 52-week high the previous day. Trading volume was above average as investors positioned ahead of next week’s earnings and a Federal Reserve meeting. The company’s 1.400% senior notes due 2026 are being delisted from the NYSE. Thermo Fisher reports fourth-quarter results before markets open on Jan. 29.
24 January 2026
··
Thermo Fisher stock slips from fresh high — what traders watch before earnings week

Thermo Fisher stock slips from fresh high — what traders watch before earnings week

Thermo Fisher Scientific shares fell 2.1% to $625.98 Friday, ending a three-day rally and retreating from a 52-week high. The drop came ahead of the company’s Jan. 29 earnings release and as peers Waters and Danaher also declined about 2%, signaling profit-taking in the life-sciences tools sector. Investors await updates on Thermo Fisher’s planned Clario acquisition and outlook for 2026.
24 January 2026
··
Thermo Fisher (TMO) stock slides as investors square up ahead of Jan. 29 results

Thermo Fisher (TMO) stock slides as investors square up ahead of Jan. 29 results

Thermo Fisher Scientific shares fell nearly 2% by midday Friday, reversing earlier gains after touching a record high near $640. The drop outpaced the broader market, with peers Danaher, Agilent, and Illumina also declining. Investors are awaiting Thermo Fisher’s fourth-quarter results, set for release before the market opens on Jan. 29. The S&P 500 was steady while the health-care sector slipped.
23 January 2026
··
Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings

Thermo Fisher stock dips today as Wall Street sizes up next week’s earnings

Thermo Fisher Scientific shares fell 1.2% to $631.70 in late morning trading Friday, ending a two-day rally as investors awaited the company’s Jan. 29 earnings report. Peers Danaher and Agilent also declined. Traders are watching for management’s outlook on demand and margins. A recent minor debt security filing drew some attention but did not involve common stock.
23 January 2026
··
Thermo Fisher stock price holds near a fresh 52-week high with earnings next week in focus

Thermo Fisher stock price holds near a fresh 52-week high with earnings next week in focus

Thermo Fisher shares closed up 0.5% at $639.43 Thursday after hitting a new 52-week high, with little change in after-hours trading. The company will report fourth-quarter and full-year results before the market opens Jan. 29. Investors are watching for signals on lab and biopharma spending. Peers Danaher and Agilent slipped, while Waters rose late Thursday.
23 January 2026
··
1 2 3 4

Stock Market Today

  • John Hancock Multifactor Small Cap ETF (JHSC) Sees Unusual Volume Spike
    April 29, 2026, 1:20 PM EDT. The John Hancock Multifactor Small Cap ETF (JHSC) experienced an unusual surge in trading volume Wednesday afternoon, with over 732,000 shares changing hands versus its typical three-month average of 27,000. Despite heightened activity, JHSC shares dipped 0.8% on the day. Key components driving volume included Mara Holdings, which fell 6.3% on a hefty 16.8 million shares traded, and Transocean, down 0.4% on 12.4 million shares. Vita Coco led gains within the ETF, surging 20.4%, while Siteone Landscape Supply struggled, shedding 17.2%. The wide swings among key holdings highlight the mixed sentiment within this small-cap multifactor ETF.

Latest article

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

General Dynamics Corporation Stock Jumps After Submarine Orders, Gulfstream Jets Lift 2026 Outlook

29 April 2026
General Dynamics raised its 2026 profit outlook after first-quarter earnings and revenue topped estimates, sending shares up 10.9% to $347.72. The company reported $1.4 billion in operating earnings and $13.5 billion in revenue, with Marine Systems revenue up 21% on submarine programs. Orders reached $26.6 billion, pushing backlog to $130.8 billion. General Dynamics ended the quarter with $3.7 billion in cash.
Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

Teva Stock Jumps As Branded Drugs Start Carrying The Old Generics Giant

29 April 2026
Teva reported first-quarter adjusted earnings of 53 cents per share on $3.98 billion revenue, beating estimates as sales of Austedo, Ajovy, and Uzedy climbed. Shares jumped 11% in New York trading. The company agreed to buy Emalex Biosciences for $700 million upfront, adding a late-stage Tourette syndrome drug candidate. Global generics revenue fell 16% amid increased competition.
Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

Silicon Motion Stock Jumps After Q1 Sales Double and AI Storage Outlook Tops Estimates

29 April 2026
Silicon Motion reported first-quarter revenue of $342.1 million, up 105% from a year earlier, and forecast second-quarter sales above Wall Street estimates. Shares rose $45.09 to $194.27 in New York trading. The company cited strong demand for embedded storage controllers and AI-related enterprise storage. CEO Wallace Kou said its MonTitan SSD controller platform will enter volume production this quarter.
Go toTop